NIH-funded research R01 grant

Understanding how trypsin activates in pancreatitis

Official title: Mechanisms of Trypsin Activation in Pancreatitis

Funded at Boston University Medical Campus · NIH-11009499 · Data updated 2026-11-12

This study is looking at how a digestive enzyme called trypsin gets activated in the pancreas, which is an important step in the development of pancreatitis, to help find better ways to understand and treat people with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 9, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$326,700
NIH project number5R01DK132471-03
Project IDNIH-11009499 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of pancreatitis or those with genetic predispositions to the condition.

Less likely to help

Patients who do not have pancreatitis or related digestive disorders may not benefit from this research.

What this research studies

This research investigates the mechanisms by which the digestive enzyme trypsin is activated in the pancreas, which is a critical early event in the development of pancreatitis. The study aims to clarify the roles of different activation pathways, including the potential influence of genetic mutations and the enzyme cathepsin B. By conducting experiments on animal models, the researchers will explore how these factors contribute to the severity and onset of pancreatitis. This knowledge could lead to better understanding and treatment options for patients suffering from this condition.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for pancreatitis, potentially reducing its severity and onset in affected patients.

How similar studies have gone: Previous research has shown promise in understanding enzyme activation in similar contexts, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Geisz-Fremy, Andrea — Boston University Medical Campus
  • Study coordinator: Geisz-Fremy, Andrea

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.